Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sepsis and the dendritic cell.

Philip Efron1, Lyle L Moldawer

  • 1Department of Surgery, University of Florida College of Medicine, Gainesville 32610, USA.

Shock (Augusta, Ga.)
|October 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age but not sex modifies lymphoid immune responses in murine sepsis.

Research square·2026
Same author

Optimization of Preclinical Rodent Research Models of Human Shock: Part 2 Trauma, Burn, and the Gut Microbiome.

Shock (Augusta, Ga.)·2026
Same author

A murine model of sepsis induces age- and sex-specific chromatin remodeling in myeloid-derived suppressor cells.

Frontiers in immunology·2026
Same author

Preterm birth skews the developmental trajectory of myeloid-derived suppressor cells in the first 48 hours of life: single-cell transcriptomics and inferred intercellular communication.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Divergent chromatin remodeling trajectories in CD66b <sup>+</sup> MDSCs distinguishes recovery from chronic critical illness after sepsis.

bioRxiv : the preprint server for biology·2026
Same author

Prolonged Loss of Oxidative Phosphorylation and Mitochondrial Mass Characterize CD66b<sup>+</sup> Leukocytes from Patients with Sepsis.

bioRxiv : the preprint server for biology·2025
Same journal

Epinephrine nebulization delays need for life-saving intervention following smoke inhalation in ovine model.

Shock (Augusta, Ga.)·2026
Same journal

Sodium-Glucose Cotransporter 2 Inhibitors as Discharge Medications in Survivors of Acute Myocardial Infarction Complicated by Cardiogenic Shock.

Shock (Augusta, Ga.)·2026
Same journal

Dynamic Temperature Modeling Predicts Mortality in Murine Sepsis.

Shock (Augusta, Ga.)·2026
Same journal

Changes of Intestinal Aquaporins after Experimental Polytrauma and Hemorrhagic Shock: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Effect of Chest Compression Release Velocity on Cerebral Perfusion Pressure in a Porcine Cardiac Arrest Model: Erratum.

Shock (Augusta, Ga.)·2026
Same journal

Ulinastatin Treatment Associated with Lower Sepsis-Associated Encephalopathy Risk in Sepsis Patients: A Multicenter Observational Study.

Shock (Augusta, Ga.)·2026
See all related articles

Sepsis treatment has seen limited progress. Research into dendritic cells, crucial for immune response, offers new therapeutic targets for improving sepsis patient outcomes.

Area of Science:

  • Immunology
  • Critical Care Medicine

Background:

  • Sepsis remains a leading cause of mortality with modest improvements in patient outcomes.
  • Current understanding of sepsis pathogenesis is evolving, necessitating updated models and definitions.

Purpose of the Study:

  • To highlight the emerging role of dendritic cells in sepsis.
  • To explore dendritic cells as potential therapeutic targets for sepsis.

Main Methods:

  • Review of current scientific literature on dendritic cell biology and sepsis.
  • Analysis of the role of dendritic cells in immune responses to infection and injury.

Main Results:

  • Dendritic cells, a type of antigen-presenting cell, are increasingly recognized for their importance in sepsis.

Related Experiment Videos

  • Evidence suggests dendritic cells play a role in both normal and detrimental responses during sepsis.

    • Conclusions:

    • Further understanding of dendritic cell biology is crucial for developing novel sepsis treatments.
    • Targeting dendritic cells holds promise for improving outcomes in patients with sepsis, severe sepsis, and septic shock.